News

Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.
If the tariff-loving Trump goes ahead with his plans, it will hit AstraZeneca - the most valuable company on the UK stock ...
CEO Emma Walmsley said the company has been anticipating tariffs on the industry and is “confident” the company can navigate through it, Ashleigh Furlong and Ruth David of Bloomberg reports. The U.S.
As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.
A string of pharmaceutical bosses attended a three-hour dinner at Donald Trump’s Mar-a-Lago resort in Florida in December.
Speculation is mounting GlaxoSmithKline's CEO Emma Walmsley may pay the price for the company’s lacklustre performance, after the dreaded activist investor Elliott Management built a stake in ...
Donald Trump has performed a dramatic U-turn on the scale of his tariffs on other countries, but this is still not a return to the status quo. The US President has rowed back on the larger tariffs ...
Nevertheless, the bullish view of GSK's pipeline prospects delivered by chief executive Emma Walmsley seemed to strike a chord with investors, as its share price rose 3% before falling back to a 1 ...
European stock markets closed mostly lower in Friday trading as the Stoxx Europe 600 was off 0.10%, Germany's DAX dropped 0.92%, the FTSE 100 in London was up 0.64%, France's CAC 40 fell 0.30%, and ...
The Oscars of accounting will emanate again from the Roundhouse in London on 30 September, but before the accounting glitterati walk the red carpet or ...
InterGrain is progressing two major capital works projects, aimed at boosting capacity and expanding the range of crops in ...